Results 1 to 10 of about 4,292,830 (340)
Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test [PDF]
Journal of Medical Screening, 2017 BACKGROUND: Screening participants with abnormal faecal occult blood test results who do not attend further testing are at high risk of colorectal cancer, yet little is known about their reasons for non-attendance.
Djedovic, N +9 more
core +2 more sources
Nonsteroidal anti-inflammatory drug-induced colopathy: An uncommon cause of positive immunochemical faecal occult blood test in the program for colorectal cancer screening [PDF]
Vojnosanitetski Pregled, 2021 Introduction. Nonsteroidal anti-inflammatory drug-induced colopathy is an uncommon condition associated with the long-term use of enteric-coated and slow-release nonsteroidal anti-inflammatory drugs.
Smolović Brigita +3 more
doaj +1 more source
Fecal occult blood testing in colorectal cancer screening programs
Исследования и практика в медицине, 2022 Colorectal carcinoma (CRC) is the third most common cancer worldwide and ranks second as a cause of cancer mortality. CRC screening is carried out in many countries for detection early-stage CRC and its prevention by removing precancerous lesions, and ...
N. V. Severskaya +4 more
doaj +1 more source
Cancers, 2021 Simple Summary There is large heterogeneity in invitation schemes and participation rates in colorectal cancer screening programs offering fecal occult blood tests (nowadays mostly fecal immunochemical tests).
L. F. Gruner +7 more
semanticscholar +1 more source
Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis
GE: Portuguese Journal of Gastroenterology, 2021 Background and Objective: Colorectal cancer (CRC) is one of the most common cancers in Europe. Recently, new data from the USA and Europe revealed an increase in the incidence of CRC in individuals aged <55 years and a reduction in those aged > ...
Pedro Currais +5 more
doaj +1 more source
The Use of M2-Pyruvate Kinase as a Stool Biomarker for Detection of Colorectal Cancer in Tertiary Teaching Hospital: A Comparative Study [PDF]
Annals of Coloproctology, 2020 Purpose Guaiac fecal occult blood test (gFOBT) has been the standard for colorectal screening but it has low sensitivity and specificity. This study evaluated the use of fecal tumor M2-pyruvate kinase (M2-PK) for detection of colorectal cancer and to ...
Shahidah Che Alhadi +7 more
doaj +1 more source
Frontiers in Medicine, 2021 Objective: The diagnostic efficiency of the quantitative fecal immunochemical test (qFIT) has large variations in colorectal cancer (CRC) screening. We aimed to explore whether the practical sample collection operant training could improve the diagnostic
Ru-chen Zhou +30 more
doaj +1 more source
Swiss Medical Weekly, 2023 AIMS OF THE STUDY: Canton Vaud, Switzerland, implemented an organised colorectal cancer screening programme with colonoscopy and faecal occult blood tests in 2015, 4 to 6 years ahead of neighbouring cantons.
Christina Hempel-Bruder +10 more
doaj +1 more source
A rare presentation of the Klinefelter's syndrome [PDF]
, 2003 A 16 years old boy with Chronic Renal Failure (CRF) was not suspected of having Klinefelter's syndrome until he complained of painful gynecomastia. He was under haemodialysis for 2 years. At first, he was in an approximately full pubertal development (P5,
A. Frank +23 more
core +2 more sources